AWM
WGSWW

Apollon Wealth Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

Apollon Wealth Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$10K – 835
2021
Q4 		$10K Hold
10,000
– – ﹤0.01% 755
2021
Q3 		$21K Buy
+10,000
New +$32.9K ﹤0.01% 468

Other funds holding WGSWW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

Apollon Wealth Management's WGSWW Position: Q1 2022 in Review

Apollon Wealth Management sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2022, closing a stake of 10,000 shares — an estimated $10K sold.

Apollon Wealth Management first reported a position in WGSWW in Q3 2021 and held it in 2 quarters. The position peaked at $21K in Q3 2021. 27 funds tracked by Wall St. Rank hold WGSWW as of Q1 2022.

  • Apollon Wealth Management reported no remaining GeneDx Holdings Warrant position as of Q1 2022 after selling out during the quarter.
  • Apollon Wealth Management sold 10,000 GeneDx Holdings Warrant shares in Q1 2022, an estimated $10K.
  • Apollon Wealth Management first reported a position in GeneDx Holdings Warrant in Q3 2021 and held it in 2 quarters.
  • Apollon Wealth Management's GeneDx Holdings Warrant position peaked at $21K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2022.

Based on Apollon Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.